Skip to main content

Agranulocytosis and granulocytopenia associated with quetiapine

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Objective: Quetiapine is a recently introduced atypical antipsychotic. Although adverse effects are mainly mild, more serious infrequent adverse effects including leucopenia are mentioned.

Method: We describe three case-reports concerning haematological adverse effects of quetiapine.

Results: Quetiapine was associated with leucopenia in two patients and clinically apparent agranulocytosis in one patient.

Conclusion: Although a definite association has not been proven, clinicians should be aware of the possibility of agranulocytosis while using quetiapine. Further post-marketing surveys are required.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: agranulocytosis; antipsychotic agents; clozapine; dibenzothiazepines; leucopenia; quetiapine

Document Type: Research Article

Affiliations: 1: MFO Psychiatrie AMC/de Meren, Academic Medical Centre, Amsterdam, The Netherlands and 2: Stichting Lareb (Netherlands Pharmacovigilance Foundation), ‘s-Hertogenbosch, The Netherlands

Publication date: 2001-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more